HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies
Jul 24, 2023 20:19 HKT |  |
|
HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies
Jul 24, 2023 19:30 HKT | |
|
RenovoRx and Imugene Announce Collaboration to Deliver Oncolytic Virus Therapy Using Proprietary Trans-Arterial Micro-Perfusion (TAMP) Platform
Jul 20, 2023 16:00 HKT |  |
|
中国三大ICL服务提供商之一艾迪康于香港联交所主板正式挂牌
Jun 30, 2023 14:27 HKT |  |
|
中國三大ICL服務提供者之一艾迪康於香港聯交所主板正式掛牌
Jun 30, 2023 14:26 HKT | |
|
ADICON Holdings Limited One of the Top Three ICL Service Providers in China is Successfully Listed on Main Board of SEHK
Jun 30, 2023 14:25 HKT | |
|
医疗板块布局正当时，关注新股ICL龙头艾迪康带来的投资机遇
Jun 21, 2023 07:07 HKT | |
|
醫療板塊佈局正當時，關注新股ICL龍頭艾迪康帶來的投資機遇
Jun 21, 2023 07:06 HKT | |
|
艾迪康宣布于港交所主板上市计划 每股作价12.32港元
Jun 19, 2023 11:39 HKT | |
|
艾迪康宣佈於港交所主板上市計劃 每股作價12.32港元
Jun 19, 2023 11:38 HKT | |
|
ADICON Announces Proposed Listing on the Main Board of The Stock Exchange of Hong Kong at an Offer Price of HK$12.32 Per Share
Jun 19, 2023 11:37 HKT | |
|
Asensus Shares First Quarter Results and Future Plans
Jun 01, 2023 21:40 HKT |  |
|
2023 ASCO和BIO上的Avance Clinical：早期肿瘤治疗试验越来越复杂，对患者的需求也越来越大
May 30, 2023 11:00 HKT |  |
|
2023 ASCO和BIO上的Avance Clinical：早期腫瘤治療試驗越來越複雜，對患者的需求也越來越大
May 30, 2023 11:00 HKT | |
|
ASCO & BIO 2023에서 아방스 임상: 점점 더 정교해지고 더 많은 환자를 요구하는 초기 단계 종양학 시험
May 30, 2023 11:00 HKT | |
|
Avance Clinical at ASCO & BIO 2023: Early Phase Oncology Trials Increasingly Elaborate and Demand More Patients
May 30, 2023 10:00 HKT | |
|
아방스 임상, 인생을 변화시키고 생명을 구하는 치료법에 대한 신속한 접근을 위해 글로벌 보건 정상회의 캠페인에 합류
May 25, 2023 16:00 HKT | |
|
Avance Clinical 加入全球健康峰会活动，以更快获得改变生活和拯救生命的疗法
May 25, 2023 13:05 HKT | |
|
Avance Clinical 加入全球健康峰會活動，以更快獲得改變生活和拯救生命的療法
May 25, 2023 13:05 HKT | |
|
Avance Clinical Joins Global Health Summit Campaign for Faster Access to Life-Changing and Life-Saving Therapies
May 25, 2023 09:00 HKT | |
|